Brief

On April 9, 2025, the Ministry of Health and Welfare (MOHW) hosted a meeting with medical device and cosmetics companies and associations to discuss countermeasures related to the US government's mutual tariff measures. The meeting aimed to minimize the impact on the biopharmaceutical industry due to the US government's tariff measures, with the MOHW stating its efforts to collaborate with relevant ministries and actively participate in international trade negotiations.

This content is restricted.

Highlights content goes here...

This content is restricted.

Ministry of Health and Welfare (MOHW)

Quick Insight
RADA.AI
RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Enter your registered username/email id.

Enter your Email

Enter your email id below to signup.
Individual Plan
$125 / month OR $1250 / year
Features
Best for: Researchers, Legal professionals, Academics
Enterprise Plan
Contact for Pricing
Features
Best for: Law Firms, Corporations, Government Bodies